09/12-15/2024,

Portaria Hotel / Pilion

During 09/12-15/2024, at Portaria Hotel / Pilion, the Society for the Study of Dermatovenereologic and Allergic Diseases (S.S.D.A.D.) organized the 7th Panhellenic Conference “Dermatological diseases: Past, present and future”.

Greek Dermatologists attended the congress and visited IASIS PHARMA exhibition stand to get informed of 3 important IASIS Dermatological products:

  • Isotroin®/ Isotretinoin, (at the new & unique 30mg dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy. Isotroin® 30mg  is added to the range of the other Isotroin® strengths  (10mg, 20mg & 40mg).
  • Combi®, a combination of fluprednidene (1mg) + miconazole (20mg) cream for the treatment of Inflammatory Dermatomycoses.
  • Modiwart®/Ιmiquimod (12,5mg/sachet), an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.

%cf%80%ce%b7%ce%bb%ce%b9%ce%bf-copy-1